Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

APLT

Applied Therapeutics (APLT)

Applied Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:APLT
FechaHoraFuenteTítuloSímboloCompañía
06/03/202519:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APLTApplied Therapeutics Inc
14/02/202517:11Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:APLTApplied Therapeutics Inc
14/02/202513:35Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:APLTApplied Therapeutics Inc
13/02/202504:45PR Newswire (US)Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLTNASDAQ:APLTApplied Therapeutics Inc
10/02/202515:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLTApplied Therapeutics Inc
10/02/202504:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLTNASDAQ:APLTApplied Therapeutics Inc
06/02/202504:45PR Newswire (US)The Gross Law Firm Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLTNASDAQ:APLTApplied Therapeutics Inc
03/02/202504:45PR Newswire (US)Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - APLTNASDAQ:APLTApplied Therapeutics Inc
30/01/202504:45PR Newswire (US)The Gross Law Firm Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLTNASDAQ:APLTApplied Therapeutics Inc
27/01/202504:45PR Newswire (US)Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLTNASDAQ:APLTApplied Therapeutics Inc
23/01/202504:45PR Newswire (US)Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact The Gross Law FirmNASDAQ:APLTApplied Therapeutics Inc
21/01/202506:00GlobeNewswire Inc.Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of QualityNASDAQ:APLTApplied Therapeutics Inc
20/01/202504:45PR Newswire (US)Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:APLTApplied Therapeutics Inc
16/01/202504:45PR Newswire (US)The Gross Law Firm Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming DeadlineNASDAQ:APLTApplied Therapeutics Inc
09/01/202504:45PR Newswire (US)Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmNASDAQ:APLTApplied Therapeutics Inc
06/01/202504:45PR Newswire (US)Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLTNASDAQ:APLTApplied Therapeutics Inc
02/01/202510:48PR Newswire (US)Investors in Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLTNASDAQ:APLTApplied Therapeutics Inc
02/01/202509:10PR Newswire (US)Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - APLTNASDAQ:APLTApplied Therapeutics Inc
20/12/202406:00GlobeNewswire Inc.Applied Therapeutics Appoints John H. Johnson as Executive ChairmanNASDAQ:APLTApplied Therapeutics Inc
19/12/202404:45PR Newswire (US)Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class Action - APLTNASDAQ:APLTApplied Therapeutics Inc
27/11/202415:10GlobeNewswire Inc.Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
14/11/202416:47Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:APLTApplied Therapeutics Inc
08/11/202413:17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:APLTApplied Therapeutics Inc
07/11/202406:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APLTApplied Therapeutics Inc
07/11/202406:00GlobeNewswire Inc.Applied Therapeutics Reports Third Quarter 2024 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
05/11/202406:00GlobeNewswire Inc.Applied Therapeutics to Present at the 2024 UBS Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
18/09/202406:00GlobeNewswire Inc.Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
04/09/202406:00GlobeNewswire Inc.Applied Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:APLTApplied Therapeutics Inc
14/08/202417:52Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:APLTApplied Therapeutics Inc
09/08/202419:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:APLTApplied Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APLT